Navigation Links
Aida Granted Additional Anti-Cancer Patent

SANTA MONICA, Calif., Oct. 11 /PRNewswire-FirstCall/ -- Aida Pharmaceuticals, Inc. (OTC Bulletin Board: AIDA), one of mainland China's leading pharmaceutical companies, today announced that it was granted an additional patent related to its Rh-Apo2L anti-cancer drug, the second of three patents that had been applied for which Aida believes places it at the vanguard of China's pharmaceutical industry. The patent was jointly granted by China's State Intellectual Property Office ("SIPO") to East China University of Science& Technology ("ECUST") and Aida's majority-controlled subsidiary, Shanghai Quiaer Biotechnology Company, Ltd ("Shanghai Qiaer"). ECUST is the partner with Aida in the research of this field.

The patent, certificate number: 200510028037.6, deals with the cultivation of Rh-Apo2L. The main content of the patent includes the following:

-- the fermentative process dividing into five stages,

-- the different stage separately increasing the different C/N culture


-- realization of C and N demand balance, and

-- that the methodology set by Aida can effectively enhance the soluble

protein expression quantity while simultaneously reducing the

fermentative process of the ethanoic acid accumulation.

Mr. Jinsong Zhou, the CEO of Shanghai Qiaer stated, "This continues to establish Aida as a technology leader in not only the Chinese pharmaceutical field, but also in the international arena. Our scientists and researchers are deeply encouraged by the news and will reinforce our confidence in the ongoing clinical trials of Rh-Apo2L."

About Rh-Apo2L -- The Anti-Cancer Drug

Rh-Apo2L is a pioneering biotechnology gene therapy drug used to treat certain forms of cancer. Rh-Apo2L has completed the Phase I clinical trials successfully in July 2006. This biopharmaceutical drug has gained the attention of researchers and clinical professionals throughout China who are observing the drug for potential replacement of surgery and radiation therapy for cancer. Potentially, over 8 million people can be treated each year in China with this drug.

About Aida Pharmaceuticals

Aida Pharmaceuticals is a product-focused pharmaceuticals company engaged in the formulation, clinical testing, registration, manufacture, sales and marketing of advanced pharmaceutical and genetic products in mainland China. The Company's mission is to discover, develop and market meaningful new therapies that improve human health. Aida Pharmaceuticals, in operation since March 1999, is headquartered in Hangzhou, China with manufacturing, distribution and sales points throughout mainland China. Aida is GMP certified in China and ISO9002 certified for quality assurance and ISO14000 certified for ecologically-friendly practices.

SOURCE Aida Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Indian Doctor granted US patent on organ regeneration
2. Bail Granted To The Doctor Despite Her Patients Death
3. Azerbaijan Granted 5 million dollars in Fight Against Bird Flu
4. Developer Of Vaccine For Cancer Granted A Prestigious Fellowship
5. Lenalidomide, Granted Approval by FDA to Join Multiple Myeloma Drugs
6. American Senior Citizens Granted More Time
7. Numerous Defense Personnel Granted Early Retirement Due to Mental Illness
8. Man Accused of Spreading HIV Granted Bail in Australia
9. Additional Radiotheraphy for Breast Cancer
10. Adding An Additional Drug May Help Patients With Glaucoma
11. Additional Responsiblities To Be Taken Up By Allied Healthcare Professionals
Post Your Comments:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Lori R. ... a member of ElderCounsel, a national organization of elder law and special needs planning ... laws and rules. It also provides a forum to network with elder law attorneys ...
(Date:10/13/2017)... BASKING RIDGE, N.J. (PRWEB) , ... October 13, 2017 , ... ... second annual Holly Day Market. Featuring a collection of specialty vendors and unique items ... myriad of personalized and quality-focused health and wellness services offered by the VNA. ...
(Date:10/13/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has ... least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a ... centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to ... to save lost souls in the Philippines. “The Journey: From the Mountains to the ... teacher of the Bible. She has taught all ages and currently teaches a class ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017 The Rebound mobile app is ... to reverse the tide of prescription drug addiction. The app ... medicine intake and stepping down their dosage in a safe, ... in December 2017; the first 100,000 people to sign up ... ...
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion ... notable awards. Ranked as number one in the South Florida ... time in Inc. 5000 yearly list, the national specialty pharmacy ... Armando Bardisa will soon be honored by SFBJ ... Set to receive his award in ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
Breaking Medicine Technology: